Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2021;71:209–49.

Google Scholar 

Yang R, Su Y, Ma R, Li Y. Clinical epidemiology of peritoneal metastases in China: the construction of professional peritoneal metastases treatment centers based on the prevalence rate. Eur J Surg Oncol. 2023;49:173–8.

PubMed  Google Scholar 

Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236–42.

CAS  PubMed  Google Scholar 

Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16:1–27.

PubMed  Google Scholar 

Coccolini F, Capponi MG, Campanati L, Piazzalunga D, Manfredi R, Colaianni N, et al. Intraperitoneal chemotherapy in advanced gastric cancer. meta-analysis of randomized trials. Eur J Surg Oncol (EJSO). 2013;39:S39-40.

Google Scholar 

Ikoma N, Chen H-C, Wang X, Blum M, Estrella JS, Fournier K, et al. Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy. Ann Surg Oncol. 2017;24:2679–87.

PubMed  Google Scholar 

Thomassen I, Gestel YR, Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622–8.

CAS  PubMed  Google Scholar 

Sun BJ, Lee B. Review of regional therapies for gastric cancer with peritoneal metastases. Cancers. 2022;14:570.

CAS  PubMed  PubMed Central  Google Scholar 

Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, et al. Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol (EJSO). 2006;32:661–5.

CAS  PubMed  Google Scholar 

Ishigami H, Fujiwara Y, Fukushima R, Nashimoto A, Yabusaki H, Imano M, et al. Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial. J Clin Oncol. 2018;36:1922–9.

CAS  PubMed  Google Scholar 

Yang Z-Y, Yuan F, Lu S, Xu W, Wu J-W, Xi W-Q, et al. Efficacy and safety of conversion therapy by intraperitoneal and intravenous paclitaxel plus oral S-1 in gastric cancer patients with peritoneal metastasis: a prospective phase II study. Front Oncol. 2022;12:905922.

CAS  PubMed  PubMed Central  Google Scholar 

Kobayashi D, Kodera Y. Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Gastric Cancer. 2017;20:111–21.

CAS  PubMed  Google Scholar 

Kitayama J, Ishigami H, Yamaguchi H, Sakuma Y, Horie H, Hosoya Y, et al. Treatment of patients with peritoneal metastases from gastric cancer. Ann Gastroenterol Surg. 2018;2:116–23.

PubMed  PubMed Central  Google Scholar 

Chia DKA, So JBY. Recent advances in intra-peritoneal chemotherapy for gastric cancer. J Gastric Cancer. 2020;20:115–26.

PubMed  PubMed Central  Google Scholar 

Yonemura Y. A new bidirectional intraperitoneal and systemic induction chemotherapy (BISIC) for the peritoneal metastasis from gastric cancer in neoadjuvant setting. Integr Cancer Sci Ther. 2014;1:26–9.

Google Scholar 

Prabhu A, Mishra D, Brandl A, Yonemura Y. Gastric cancer with peritoneal metastasis—a comprehensive review of current intraperitoneal treatment modalities. Front Oncol. 2022;12:864647.

CAS  PubMed  PubMed Central  Google Scholar 

Han T-S, Kong S-H, Lee H-J, Ahn H-S, Hur K, Yu J, et al. Dissemination of free cancer cells from the gastric lumen and from perigastric lymphovascular pedicles during radical gastric cancer surgery. Ann Surg Oncol. 2011;18:2818–25.

PubMed  Google Scholar 

Virgilio E, Giarnieri E, Giovagnoli MR, Montagnini M, Proietti A, D’Urso R, et al. Gastric cancer cells in peritoneal lavage fluid: a systematic review comparing cytological with molecular detection for diagnosis of peritoneal metastases and prediction of peritoneal recurrences. Anticancer Res. 2018;38:1255–62.

CAS  PubMed  Google Scholar 

Fidler IJ. The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisited. Nat Rev Cancer. 2003;3:453–8.

CAS  PubMed  Google Scholar 

Kanda M, Kodera Y. Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol. 2016;22:6829–40.

CAS  PubMed  PubMed Central  Google Scholar 

Ge W, Chen G, Fan X-S. Pathway of peritoneal carcinomatosis maybe hematogenous metastasis rather than peritoneal seeding. Oncotarget. 2017;8:41549–54.

PubMed  PubMed Central  Google Scholar 

Asmar AE, Veys I, Larsimont D, Donckier V, Liberale G. Inferior epigastric artery lymph nodes: a pathway for systemic dissemination from peritoneal carcinomatosis? J Surg Oncol. 2021;123:311–4.

PubMed  Google Scholar 

Gwee YX, Chia DKA, So J, Ceelen W, Yong WP, Tan P, et al. Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis. J Clin Oncol. 2022;40:2830.

CAS  PubMed  PubMed Central  Google Scholar 

Kodera Y, Ito S, Mochizuki Y, Ohashi N, Tanaka C, Kobayashi D, et al. Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study. Gastric Cancer. 2012;15:335–7.

PubMed  Google Scholar 

Yamaguchi T, Takashima A, Boku N. ASO author reflections: what is the best treatment for gastric cancer with positive peritoneal lavage cytology or localized peritoneum metastasis? Ann Surg Oncol. 2020;27:737–8.

PubMed  Google Scholar 

Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, et al. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg. 1999;178:256–62.

CAS  PubMed  Google Scholar 

Jamel S, Markar SR, Malietzis G, Acharya A, Athanasiou T, Hanna GB. Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis. Gastric Cancer. 2018;21:10–8.

CAS  PubMed  Google Scholar 

Roviello F, Marrelli D, de Manzoni G, Morgagni P, Leo AD, Saragoni L, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003;90:1113–9.

CAS  PubMed  Google Scholar 

Shimada S, Yagi Y, Shiomori K, Honmyo U, Hayashi N, Matsuo A, et al. Characterization of early gastric cancer and proposal of the optimal therapeutic strategy. Surgery. 2001;129:714–9.

CAS  PubMed  Google Scholar 

Huang B, Sun Z, Wang Z, Lu C, Xing C, Zhao B, et al. Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database. BMC Cancer. 2013;13:57.

PubMed  PubMed Central  Google Scholar 

Iwasaki Y, Terashima M, Mizusawa J, Katayama H, Nakamura K, Katai H, et al. Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial. Gastric Cancer. 2021;24:492–502.

CAS  PubMed  Google Scholar 

Esaki Y, Hirayama R, Hirokawa K. A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer. 1990;65:2086–90.

CAS  PubMed  Google Scholar 

Andrade JPD, Mezhir JJ. The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review. J Surg Oncol. 2014;110:291–7.

PubMed  Google Scholar 

Zhou C, Wang Y, Ji M-H, Tong J, Yang J-J, Xia H. Predicting peritoneal metastasis of gastric cancer patients based on machine learning. Cancer Control. 2020;27:1073274820968900.

PubMed  PubMed Central  Google Scholar 

Association JGC. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer. 2023;26:1–25.

Google Scholar 

Wang F, Zhang X, Li Y, Tang L, Qu X, Ying J, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. 2021;41:747–95.

Google Scholar 

Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2022;20:167–92.

CAS  Google Scholar 

Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res. 1980;40:256–60.

CAS  PubMed  Google Scholar 

Cui S, Liang H, Li Y, Zhou Y, Tao K, Zhou Z, et al. PILGRIM: phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy (HIPEC-01). J Clin Oncol. 2020;38:4538. https://doi.org/10.1200/JCO.2020.38.15_suppl.4538.

Google Scholar 

Reutovich MYU, Krasko OV, Sukonko OG. Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review. J Gastrointest Oncol. 2020;12:S5-17.